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On page 7094, [Table 2](#T0001){ref-type="table"} should be presented as follows: Table 2Multivariate analysis using a cox proportional hazards model in patients with early stage SCLCVariableMultivariable analysis^a^HR95% CI*P*Age, year\<0.001 \<45Reference ≥45, \<554.9611.208--20.3740.026 ≥55, \<655.0081.238--20.2570.024 ≥65, \<755.6181.391--22.6810.015 ≥757.3811.824--29.8700.005Sex0.008 FemaleReference Male1.2011.050--1.374Tumor size, cm0.002 ≤1Reference \>1, ≤21.1800.868--1.6040.292 \>2, ≤31.2170.893--1.6580.213 \>3, ≤41.3460.975--1.8580.071 \>4, ≤51.7701.268--2.4710.001 Unknown1.1920.163--8.7350.863Surgery\<0.001 NoReference Yes0.4990.420--0.594Radiotherapy\<0.001 NoReference Yes0.5520.411--0.742Chemotherapy0.942 NoReference Yes0.9930.822--1.200Adjuvant therapy0.839 NoneReference Chemoradiotherapy1.0350.742--1.445Insurance status0.495 MedicaidReference Uninsured1.2880.724--2.2900.390 Unknown0.8690.621--1.2150.411 Insured0.9000.709--1.1420.386Year of diagnosis\<0.001 2004--2007Reference 2008--20111.2550.975--1.6170.078 2012--20152.3711.828--3.075\<0.001[^1][^2]

Following a review of the data post-publication, the authors found [Table 2](#T0001){ref-type="table"} was misaligned. This replacement of [Table 2](#T0001){ref-type="table"} has no impact to the findings of the study.

[^1]: **Notes:** ^a^multivariate analysis for age, sex, tumor size, surgery, radiotherapy, chemotherapy, insurance status, adjuvant therapy and year of diagnosis.

[^2]: **Abbreviations:** SCLC, small-cell lung cancer; HR, hazard ratio; CI, confidence interval.
